Browsing by Author "S.K. Katiyar"

Now showing 1 - 3 of 3

Indian Guidelines on Nebulization Therapy
(Tuberculosis Association of India, 2022) S.K. Katiyar; S.N. Gaur; R.N. Solanki; Nikhil Sarangdhar; J.C. Suri; Raj Kumar; G.C. Khilnani; Dhruva Chaudhary; Rupak Singla; Parvaiz A. Koul; Ashok A. Mahashur; A.G. Ghoshal; D. Behera; D.J. Christopher; Deepak Talwar; Dhiman Ganguly; H. Paramesh; K.B. Gupta; Mohan Kumar T; P.D. Motiani; P.S. Shankar; Rajesh Chawla; Randeep Guleria; S.K. Jindal; S.K. Luhadia; V.K. Arora; V.K. Vijayan; Abhishek Faye; Aditya Jindal; Amit K. Murar; Anand Jaiswal; Arunachalam M; A.K. Janmeja; Brijesh Prajapat; C. Ravindran; Debajyoti Bhattacharyya; George D'Souza; Inderpaul Singh Sehgal; J.K. Samaria; Jogesh Sarma; Lalit Singh; M.K. Sen; Mahendra K. Bainara; Mansi Gupta; Nilkanth T. Awad; Narayan Mishra; Naveed N. Shah; Neetu Jain; Prasanta R. Mohapatra; Parul Mrigpuri; Pawan Tiwari; R. Narasimhan; R. Vijai Kumar; Rajendra Prasad; Rajesh Swarnakar; Rakesh K. Chawla; Rohit Kumar; S. Chakrabarti; Sandeep Katiyar; Saurabh Mittal; Sonam Spalgais; Subhadeep Saha; Surya Kant; V.K. Singh; Vijay Hadda; Vikas Kumar; Virendra Singh; Vishal Chopra; Visweswaran B
Inhalational therapy, today, happens to be the mainstay of treatment in obstructive airway diseases (OADs), such as asthma, chronic obstructive pulmonary disease (COPD), and is also in the present, used in a variety of other pulmonary and even non-pulmonary disorders. Hand-held inhalation devices may often be difficult to use, particularly for children, elderly, debilitated or distressed patients. Nebulization therapy emerges as a good option in these cases besides being useful in the home care, emergency room and critical care settings. With so many advancements taking place in nebulizer technology; availability of a plethora of drug formulations for its use, and the widening scope of this therapy; medical practitioners, respiratory therapists, and other health care personnel face the challenge of choosing appropriate inhalation devices and drug formulations, besides their rational application and use in different clinical situations. Adequate maintenance of nebulizer equipment including their disinfection and storage are the other relevant issues requiring guidance. Injudicious and improper use of nebulizers and their poor maintenance can sometimes lead to serious health hazards, nosocomial infections, transmission of infection, and other adverse outcomes. Thus, it is imperative to have a proper national guideline on nebulization practices to bridge the knowledge gaps amongst various health care personnel involved in this practice. It will also serve as an educational and scientific resource for healthcare professionals, as well as promote future research by identifying neglected and ignored areas in this field. Such comprehensive guidelines on this subject have not been available in the country and the only available proper international guidelines were released in 1997 which have not been updated for a noticeably long period of over two decades, though many changes and advancements have taken place in this technology in the recent past. Much of nebulization practices in the present may not be evidence-based and even some of these, the way they are currently used, may be ineffective or even harmful. Recognizing the knowledge deficit and paucity of guidelines on the usage of nebulizers in various settings such as inpatient, out-patient, emergency room, critical care, and domiciliary use in India in a wide variety of indications to standardize nebulization practices and to address many other related issues; National College of Chest Physicians (India), commissioned a National task force consisting of eminent experts in the field of Pulmonary Medicine from different backgrounds and different parts of the country to review the available evidence from the medical literature on the scientific principles and clinical practices of nebulization therapy and to formulate evidence-based guidelines on it. The guideline is based on all possible literature that could be explored with the best available evidence and incorporating expert opinions. To support the guideline with high-quality evidence, a systematic search of the electronic databases was performed to identify the relevant studies, position papers, consensus reports, and recommendations published. Rating of the level of the quality of evidence and the strength of recommendation was done using the GRADE system. Six topics were identified, each given to one group of experts comprising of advisors, chairpersons, convenor and members, and such six groups (A-F) were formed and the consensus recommendations of each group was included as a section in the guidelines (Sections I to VI). The topics included were: A. Introduction, basic principles and technical aspects of nebulization, types of equipment, their choice, use, and maintenance B. Nebulization therapy in obstructive airway diseases C. Nebulization therapy in the intensive care unit D. Use of various drugs (other than bronchodilators and inhaled corticosteroids) by nebulized route and miscellaneous uses of nebulization therapy E. Domiciliary/Home/Maintenance nebulization therapy; public & health care workers education, and F. Nebulization therapy in COVID-19 pandemic and in patients of other contagious viral respiratory infections (included later considering the crisis created due to COVID-19 pandemic). Various issues in different sections have been discussed in the form of questions, followed by point-wise evidence statements based on the existing knowledge, and recommendations have been formulated. © 2022 Tuberculosis Association of India
Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis
(2004) V.S. Saxena; K. Venkateshwarlu; P. Nadig; H.C. Barbhaiya; N. Bhatia; D.M. Borkar; R.S. Gill; R.K. Jain; S.K. Katiyar; K.V. Nagendra Prasad; K.M. Nalinesha; K. Nasiruddin; J.P. Rishi; J. Roy Chowdhury; P.S. Saharia; B. Thomas; D. Bagchi
Allergic rhinitis is the most frequently occurring immunological disorder. It affects men, women and children and represents significant cost in terms of suffering and loss of productivity. Allergy is termed as an excessive reaction to an environmental allergen. Pollen, mold, dust, mite and animal allergens that contact the nasal or eye lining cause sneezing, nasal congestion and itchy, watery, swollen, red eyes. Although a broad spectrum of therapeutic options is available, the treatment of allergic rhinitis appears to be far from satisfactory. A novel polyherbal formulation (PF; Aller-7/NR-A2) comprising seven medicinal herbal extracts was assessed in a multicenter clinical trial involving 545 patients (321 males and 224 females) aged 18-59 years for 12 weeks to evaluate its clinical efficacy in patients suffering from allergic rhinitis. A total of 171 patients participated in double-blind, randomized, placebo-controlled studies in three centers, while 374 patients were included in the open-label studies in 11 centers. The three major symptoms (sneezing, rhinorrhea and nasal congestion) of allergic rhinitis were significantly reduced. Significant improvement was also observed in absolute eosinophil count, mucociliary clearance time, peak expiratory flow rate and peak nasal flow rate. No serious adverse events that warranted cessation of treatment were observed. Minor adverse effects were noted in both the treatment and placebo groups. Thus, this study demonstrates that Aller-7/NR-A2 is well tolerated and efficacious in patients with allergic rhinitis.
Pleural effusion guidelines from ICS and NCCP Section 1: Basic principles, laboratory tests and pleural procedures
(Wolters Kluwer Medknow Publications, 2024) Devasahayam J. Christopher; Richa Gupta; Balamugesh Thangakunam; Jefferson Daniel; Surinder K. Jindal; Surya Kant; Prashant N. Chhajed; K.B. Gupta; Sahajal Dhooria; Sudhir Chaudhri; Dhruva Chaudhry; Dharmesh Patel; Ravindra Mehta; Rakesh K. Chawla; Arjun Srinivasan; Arvind Kumar; Shakti K. Bal; Prince James; Jebin S Roger; Avinash A. Nair; S.K. Katiyar; Ritesh Agarwal; Raja Dhar; Ashutosh N. Aggarwal; J.K. Samaria; Digambar Behera; Karan Madan; Raj B Singh; S.K. Luhadia; Nikhil Sarangdhar; George D' Souza; Amita Nene; Akhil Paul; Vimi Varghese; T.V. Rajagopal; M. Arun; Shraddha Nair; Dhivya A Roy; Benjamin E. Williams; Shona A. Christopher; Dhanawade V. Subodh; Nishant Sinha; Barney Isaac; Ashwin A. Oliver; N. Priya; Jedidiah Deva; Sujith T. Chandy; Richu Bob Kurien
Pleural effusion is a common problem in our country, and most of these patients need invasive tests as they can't be evaluated by blood tests alone. The simplest of them is diagnostic pleural aspiration, and diagnostic techniques such as medical thoracoscopy are being performed more frequently than ever before. However, most physicians in India treat pleural effusion empirically, leading to delays in diagnosis, misdiagnosis and complications from wrong treatments. This situation must change, and the adoption of evidence-based protocols is urgently needed. Furthermore, the spectrum of pleural disease in India is different from that in the West, and yet Western guidelines and algorithms are used by Indian physicians. Therefore, India-specific consensus guidelines are needed. To fulfil this need, the Indian Chest Society and the National College of Chest Physicians; the premier societies for pulmonary physicians came together to create this National guideline. This document aims to provide evidence based recommendations on basic principles, initial assessment, diagnostic modalities and management of pleural effusions. © The Author(s) 2024.